Caplin Point Laboratories Limited concluded its 35th Annual General Meeting (AGM) on September 25, 2026, approving the re-appointment of Dr. Sridhar Ganesan as Managing Director and the appointment of Mr. D. Muralidharan as Whole-Time Director.

The meeting was conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM) at 10:00 am IST, in compliance with Ministry of Corporate Affairs guidelines and SEBI Listing Regulations. The Chairman, Mr. C. C. Paarthipan, confirmed the requisite quorum and initiated proceedings, noting that all Directors except Mr. Ashok Partheeban were present.

Leadership and governance updates

The Chairman apprised shareholders of recent governance changes approved via Postal Ballot on January 31, 2026. These included the appointment of Mr. Ashok Partheeban and Mr. Vivek Partheeban as Directors and Vice-Chairmen, along with Dr. K. C. John and Ms. Susan Mathew as Non-Executive Independent Directors.

During the AGM, shareholders voted on several critical leadership mandates:

• Managing Director: Re-appointment of Dr. Sridhar Ganesan for a further period of two years.
• Whole-Time Director: Appointment of Mr. D. Muralidharan for two years.
• Chairman: Continuation of Mr. C. C. Paarthipan as Chairman and Non-Executive, Non-Independent Director.

Financial performance and business highlights

Dr. Sridhar Ganesan delivered a presentation on the company’s performance and its subsidiaries. Mr. Vivek Partheeban addressed the Regulated Markets business, while Mr. D. Muralidharan, serving as Whole-Time Director and Chief Financial Officer, briefed members on financial metrics. The audited standalone and consolidated financial statements for FY26 were taken as read, alongside the Annual Report.

The Statutory Audit Report and Secretarial Audit Report were confirmed to be free from qualifications. Consequently, these reports were treated as read under Section 145 of the Companies Act, 2013.

Resolution details

The following resolutions were subject to electronic voting, comprising remote e-voting from September 22 to September 24, 2026, and e-voting during the AGM:

Meeting closure and voting results

Out of three registered speaker shareholders, two were present, with one raising queries that were addressed by the Company Secretary. The meeting concluded at 10:51 am with a vote of thanks by Dr. Sridhar Ganesan. Consolidated voting results for all resolutions will be announced within two working days to the stock exchanges and posted on the company website.

Caplin Point Laboratories has scheduled its 35th Annual General Meeting for September 25, 2026. The meeting will be held via Video Conferencing or Other Audio-Visual Means at 10:00 am.

The Board has recommended a final dividend of ₹4 per equity share of face value ₹2 each. This adds to the interim dividend of ₹4 already declared, bringing the total dividend for FY26 to ₹8 per share (400%). Shareholders on record as of September 18, 2026 will be eligible for the final payout.

Key Agenda Items

The meeting agenda focuses on adopting financial statements and approving significant board-level appointments and continuations.

Board Appointments and Continuations

Three special resolutions require shareholder approval regarding the company's leadership structure:

• Re-appointment of Managing Director: Dr. Sridhar Ganesan (DIN: 06819026) seeks re-appointment as Managing Director for two years, from August 25, 2026, to August 24, 2028. His annual salary is set at ₹55,20,000, with additional perquisites subject to Schedule V limits.
• Continuation of Chairman: Mr. C. C. Paarthipan (DIN: 01218784) seeks approval to continue as Chairman and Non-Executive, Non-Independent Director despite attaining the age of 75 during his tenure. He receives no remuneration.
• Appointment of Whole-Time Director: Mr. D. Muralidharan (DIN: 08301904), currently the Chief Financial Officer, is appointed as Whole-Time Director for two years starting August 12, 2026. His annual salary is fixed at ₹62,37,600. He will continue to serve as CFO without additional compensation.

E-Voting Details

Remote e-voting opens on September 22, 2026, at 9:00 am and closes on September 24, 2026, at 5:00 pm. The cut-off date for determining voting eligibility is September 18, 2026. Members can vote via the National Securities Depository Limited platform.